Advances of salivary proteomics in oral squamous cell carcinoma (OSCC) detection: An update

39Citations
Citations of this article
95Readers
Mendeley users who have this article in their library.

Abstract

Oral cancer refers to malignancies that have higher morbidity and mortality rates due to the late stage diagnosis and no early detection of a reliable diagnostic marker, while oral squamous cell carcinoma (OSCC) is amongst the world's top ten most common cancers. Diagnosis of cancer requires highly sensitive and specific diagnostic tools which can support untraceable hidden sites of OSCC, yet to be unleashed, for which plenty of biomarkers are identified; the most recommended biomarker detection medium for OSCC includes biological fluids, such as blood and saliva. Saliva holds a promising future in the search for new clinical biomarkers that are easily accessible, less complex, accurate, and cost effective as well as being a non-invasive technique to follow, by analysing the malignant cells' molecular pathology obtained from saliva through proteomic, genomic and transcriptomic approaches. However, protein biomarkers provide an immense potential for developing novel marker-based assays for oral cancer, hence this current review offers an overall focus on the discovery of a panel of candidates as salivary protein biomarkers, as well as the proteomic tools used for their identification and their significance in early oral cancer detection.

Cite

CITATION STYLE

APA

Khan, R. S., Khurshid, Z., Akhbar, S., & Moin, S. F. (2016, December 1). Advances of salivary proteomics in oral squamous cell carcinoma (OSCC) detection: An update. Proteomes. MDPI AG. https://doi.org/10.3390/proteomes4040041

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free